Microdosing Terzepatide: A Closer Look

This chapter explores the microdosing of terzepatide, focusing on its unconventional 0.5 milligram dosage and the implications for inflammation rather than weight loss. It discusses early trial results, comparisons with dulaglutide, and the importance of biomarkers in evaluating drug effectiveness for managing blood glucose and insulin secretion.